Untreated | Treated | p-value | |
---|---|---|---|
No. of patients | 35 | 37 | |
Age (years) | 53 ± 17 | 56 ± 16 | 0.65, ns |
Sex (M/F) | 16/19 | 26/11 | 0.034 |
Baseline eGFR ml/min/1.73 m2 | 77 ± 27 | 69 ± 25 | 0.19, ns |
eGFR < 60 ml/min/1.73 m2 | 34% | 32% | 0.8, ns |
BP ≥140/90 mmHg | 52% | 51% | 0.89, ns |
ACR mg/mmol | 350 ± 242 | 379 ± 185 | 0.57, ns |
FE IgG | 0.040 ± 0.055 | 0.067 ± 0.069 | 0.07, ns |
FE α1m | 0.325 ± 0.382 | 0.435 ± 0.411 | 0.24, ns |
GGS (%) | 7.7 ± 10.7 | 11.3 ± 17.7 | 0.30, ns |
TIF score | 1.0 ± 0.9 | 1.4 ± 1.3 | 0.19, ns |
Time to reach ESRD (months) | 55 ± 29 | 90 ± 46 | 0.07, ns |